<PAGE>
EXHIBIT 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected Financial
Data" and "Experts" in the Registration Statement (Form S-3) and related
Prospectus of Ribozyme Pharmaceuticals, Inc. for the registration of 2,887,188
shares of its common stock and to the incorporation by reference therein of our
report dated February 9, 2000, with respect to the financial statements of
Ribozyme Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the
year ended December 31, 1999, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Denver, Colorado
July 3, 2000
-31-
